Biotest GmbH & Co. KGaA (HAM:BIO0)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
European Union	264.60M	-
Rest of The World	251.50M	-
Therapy	-	461.60M
Plasma & Services	-	46.70M
Other	-	7.30M
Total	516.10M	515.60M

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Germany	600.00M	684.80M	616.20M	393.20M	-
Rest of World	48.90M	41.40M	68.40M	122.80M	-
Central Europe	-	-	-	-	186.90M
Eastern and Southern Europe, Central Asia, America*	-	-	-	-	138.10M
Other	-	-	-	-	75.90M
Middle East, Africa and France	-	-	-	-	114.70M
Total	648.90M	726.20M	684.60M	516.00M	515.60M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error